Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy

被引：0
|
作者：
Alison M. Pease
Luis A. Riba
Ryan A. Gruner
Nadine M. Tung
Ted A. James
机构：
[1] Harvard Medical School,Department of Surgery, Beth Israel Deaconess Medical Center
[2] Harvard Medical School,Department of Surgery/Linsey BreastCare Center, Beth Israel Deaconess Medical Center
[3] Harvard Medical School,Department of Medicine/Division of Hematology – Oncology, Beth Israel Deaconess Medical Center
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：366 / 371
页数：5
相关论文
共 50 条
  • [31] Ki67 as an important predictor for oncotype Dx recurrence score risk groups in early breast cancer
    Namuche, F.
    Ruiz, R. E.
    Morante Cruz, Z. D.
    Urrunaga, D.
    Aguilar Cartagena, A.
    Gomez Moreno, H. L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Assessment of method of breast cancer detection and Oncotype DX recurrence score
    Kelly, Ciara Marie
    Parker, Imelda
    McCaffrey, John
    Crown, John
    O'Connor, Miriam
    McGee, Sharon F.
    Pusztai, Lajos
    Kelly, Catherine M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma
    Bomeisl, Philip E.
    Thompson, Cheryl L.
    Harris, Lyndsay N.
    Gilmore, Hannah L.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (12) : 1546 - 1549
  • [34] Comparison of Oncotype DX™ Recurrence Score by Histologic Subtype of Breast Carcinoma
    Bomeisl, P. E.
    Thompson, C. L.
    Harris, L. N.
    Gilmore, H. L.
    LABORATORY INVESTIGATION, 2013, 93 : 30A - 31A
  • [35] Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score
    Puneet Singh
    Sarah E. Tevis
    Carolyn S. Hall
    Salyna Meas
    Rosa F. Hwang
    Anthony Lucci
    Breast Cancer Research and Treatment, 2020, 184 : 683 - 687
  • [36] Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score
    Singh, Puneet
    Tevis, Sarah E.
    Hall, Carolyn S.
    Meas, Salyna
    Hwang, Rosa F.
    Lucci, Anthony
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (03) : 683 - 687
  • [37] Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score
    Sahebjam, S.
    Aloyz, R.
    Pilavdzic, D.
    Brisson, M-L
    Ferrario, C.
    Bouganim, N.
    Cohen, V.
    Miller, W. H., Jr.
    Panasci, L. C.
    BRITISH JOURNAL OF CANCER, 2011, 105 (09) : 1342 - 1345
  • [38] Comparison of Oncotype DX™ Recurrence Score by Histologic Subtype of Breast Carcinoma
    Bomeisl, P. E.
    Thompson, C. L.
    Harris, L. N.
    Gilmore, H. L.
    MODERN PATHOLOGY, 2013, 26 : 30A - 31A
  • [39] Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma
    Sahin, A.
    BREAST DISEASES, 2016, 27 (02): : 129 - 130
  • [40] Impact of Oncotype DX Recurrence Score in the Management of Breast Cancer Cases
    Nguyen, Michaela T.
    Stessin, Alexander
    Nagar, Himanshu
    D'Alfonso, Timothy M.
    Chen, Zhengming
    Cigler, Tessa
    Hayes, Mary Kay
    Shin, Sandra J.
    CLINICAL BREAST CANCER, 2014, 14 (03) : 182 - 190
12345